# Rifabutin

NDC: 10135-738
Generic name: Rifabutin
Labeler / Manufacturer: Marlex Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220501

FDA application: ANDA215041

## Active ingredients

- RIFABUTIN: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10135-738"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10135-738
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=df7d4103-42e4-4e4f-e053-2a95a90a8ce8